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Abstract Some of the excitatory effects of norepinephrine
on central neurons are mediated by alpha-1 (a1) adreno-
ceptors. These receptors are coupled to the Gq family of
G proteins, and hence stimulate hydrolysis of the membrane
phospholipid phosphatidylinositol-4,5-bisphosphate. Other
receptors of this type can excite neurons by inhibiting the
subthreshold voltage-gated potassium M-current. We tested
this possibility using rat sympathetic neurons transformed to
express a1a receptors. The a1 agonist phenylephrine
strongly inhibited the M-current recorded under voltage-
clamp by 72 ± 11 % (n = 4) and in an unclamped neuron
dramatically increased the number of action potentials pro-
duced by a 2 s depolarizing current step from 2 to 40, without
effect on control neurons devoid of a1 receptors. We suggest
that this might be a potential cause of the increased excit-
ability produced by norepinephrine in some central neurons.
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Introduction
Alpha-1 (a1) adrenoceptors are widely distributed in the
central nervous system (Jones et al. 1985; Day et al. 1997).
There they mediate some of the effects of norepinephrine,
including a membrane depolarization and enhanced action
potential firing (e.g., supra-optic nucleus: Ogata and
Matsuo 1986; cultured spinal neurons: Legendre et al.
1988; cerebral cortex and thalamus: McCormick et al.
1991; lateral geniculate nucleus: McCormick 1992).
These receptors are G protein-coupled receptors
(GPCRs) that link primarily to the Gq family of G proteins
and thereby stimulate hydrolysis of the membrane
phospholipid phosphatidylinositol-4,5-bisphosphate (PIP2)
(Hawrylyshyn et al. 2004). Other receptors of this type can
excite neurons by inhibiting the subthreshold voltage-gated
K? current termed the ‘‘M-current’’ (Delmas and Brown
2005), which normally acts as a brake on firing activity.
However, this action does not appear to have been hitherto
detected in mammalian central neurons following a1-
stimulation. This may be because most of the cells studied
so far did not possess prominent M-currents, or perhaps
because the current is not very responsive to a1 receptor
stimulation (though tests on peripheral parasympathetic
neurons suggest otherwise: Shibata and Taketani 2001).
We have recently had an opportunity to assess the
response of M-currents to specific a1-adrenoceptor stimu-
lation using neurons from the rat superior cervical sym-
pathetic ganglion. These have large M-currents (Constanti
and Brown 1981) but do not seem to possess an appreciable
number of endogenous a1 receptors (Grayson et al. 1998;
Dawson et al. 2010). Hence we inserted a1a adrenoceptors
by intranuclear cDNA injection, as used for other receptors
(see Ikeda 1997; Filippov et al. 2000). We show that this
receptor is indeed well capable of inhibiting the M-current,
and can thereby strikingly enhance excitability.
Materials and Methods
Superior cervical sympathetic ganglia were isolated from
18-day-old rats (killed by UK Home Office approved meth-
ods), neurons dissociated, plated and cultured in vitro for
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1–2 days as described by Filippov et al. (1998). To express
a1a receptors, a cDNA plasmid encoding the receptor (pro-
vided by Dr. John Pediani, Glasgow University; see Pediani
et al. 2000) was injected into individual cell nuclei 4 h after
initial plating, together with a cDNA plasmid encoding the
jellyfish enhanced green fluorescent protein (eGFP) to mark
the injected neurons. For electrophysiological recording, cells
were patched with electrodes containing (in mM) 90 potas-
sium acetate, 20 KCl, 3 MgCl2, 40 HEPES, and 0.1 BAPTA
(pH-adjusted to 7.4 by KOH), and back-filled with the same
solution containing 0.125 mg/ml amphotericin B as a mem-
brane permeabilizing agent, to provide ‘‘perforated-patch’’
recording. (This is essential to retain the normal cytosolic
constituents and maintain normal M-currents and excitabil-
ity.) Cells were maintained in flowing Krebs’ solution at
20–22 C containing (in mM) 120 NaCl, 3 KCl, 1.5 MgCl2,
2.5 CaCl2, 10 HEPES, and 11.1 glucose (pH-adjusted to 7.3
with NaOH). Recordings were made, data collected and
analyzed as described by Filippov et al. (1998).
Results
M-Current
When these sympathetic neurons are clamped at a depo-
larized membrane potential, potassium M-channels open
and generate a steady outward current (they do not inac-
tive). Then when the cells are briefly hyperpolarized
M-channels slowly close, producing a slow inward tail-
current (see Fig. 1a). The amount of M-current lost during
the hyperpolarization can be measured from the initial
amplitude of this deactivation tail-current at the point of
hyperpolarization. This procedure isolates M-current from
other membrane currents (Adams et al. 1982a).
In neurons that had not been transformed to express a1a
adrenoceptors, the a1-agonist phenylephrine (10 lM) had
no effect on either the amount of steady outward current or
the amplitude of the deactivation tail-current (Fig. 1a, top
trace; Fig. 1c). In contrast, in the same neuron the mus-
carinic acetylcholine-receptor agonist oxotremorine-M
(oxo-M, 10 lM) clearly reduced both steady outward
current and deactivation current-tail (Fig. 1a, lower trace),
signaling M-current inhibition (see Adams et al. 1982b).
Mean inhibition in three such neurons measured from the
extrapolated initial amplitude of the deactivation tail-cur-
rent (Adams et al. 1982a) was 59 ± 14 % (Fig. 1c).
In contrast to the negative effect of phenylephrine in
Fig. 1a, this a1-agonist clearly did reduce the M-current if
a neuron had been pre-injected with a1a receptor cDNA
(Fig. 1b), to a mean extent of 72 ± 11 % (n = 4; Fig. 1c).
Thus, in an a1a-expressing neuron, phenylephrine inhibits
the M-current just like a muscarinic agonist.
Excitability
M-current confers strong spike-frequency adaptation on
these neurons, so one effect of M-current inhibition is to
facilitate repetitive firing during sustained depolarization
(Brown 1983). Figure 2a shows such an effect of oxotre-
morine-M. A 2 s depolarizing current injection initially
generated only two action potentials at the beginning of the
pulse but a sustained train of action potentials after adding
oxotremorine-M, rising to 50 action potentials (25 Hz)
with increasing current injections (Fig. 2c). Phenylephrine
had no effect on induced action potential firing in normal
cells but precisely replicated the effect of oxotremorine-M
in a neuron pre-injected with the a1a cDNA (Fig. 2b, c).
Thus, M-current inhibition by a1a-adrenoceptors would be
expected to increase neuronal excitability.
Discussion
These experiments show that, when present in a neuron,
a1-adrenoceptors are well capable of strongly inhibiting
the M-current and greatly increasing neuronal excitability,
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Fig. 1 M-current inhibition by oxotremorine-M (oxo-M, 10 lM) and
phenylephrine (phe, 10 lM). Left side voltage-clamp current records
from a a normal (wild-type) neuron and b a neuron pre-injected with
cDNA encoding the a1a-adrenoceptor. Neurons were held at -20 mV
to activate the M-current as a steady component of outward current.
Records show responses to a -20 mV 1 s hyperpolarizing step.
M-current deactivation is seen as a slow inward current-tail. c Bar
charts showing mean% inhibition measured from deactivation
current-tail amplitudes. Bars SEMs, n number of cells tested.
Currents reverted to control on drug washout. Note that phenylephrine
inhibited M-current in a1a-expressing neurons but not in control
neurons
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just like an endogenous Gq-coupled GPCR such as the
muscarinic M1-receptor.
It could be argued that this is an artifact of receptor
overexpression, and that any endogenous a1-receptors are
somehow insulated from exerting such an effect. For
example, muscarinic receptor overexpression in these
neurons can overcome endogenous barriers that otherwise
restrict downstream Ca2?-signaling pathways (Zaika et al.
2011). However, we think this type of exclusion zone
unlikely to confer resistance of M-channels to inhibition,
since, in previous tests, we found that overexpression of the
small number of endogenous P2Y1 purinoceptors, while
amplifying the signals, did not qualitatively alter their
actions on M-channels and Ca2?-channels (Filippov et al.
2010). Further, endogenous a1-adrenoceptors have been
reported to inhibit M-currents in other peripheral neurons
(Shibata and Taketani 2001).
In previous experiments on central neurons (see
‘‘Introduction’’), the depolarization produced by a1-
receptor activation was usually accompanied by a reduced
K? conductance but in only one case (cultured embryonic
spinal neurons: Legendre et al. 1988) did the depolariza-
tion show some, though not all, of the properties expected
for M-current inhibition. Probably M-currents were
insufficiently prominent in the other cells tested. Not-
withstanding, bearing in mind the wide distribution of
both M-channels and a1 receptors in the brain, it seems
likely that more of the a1-mediated effects of norepi-
nephrine on central neurons will prove to be caused by
M-channel inhibition when examined in detail. There are
only a few thousand noradrenergic neurons in their main
site of origin in the locus coeruleus, but their axons
ramify widely throughout the c.n.s. (Berridge and
Waterhouse 2003), and their activation of a1-receptors are
thought to be involved in many aspects of central nor-
adrenergic function, including memory and cognition
(Gibbs and Summers 2002; Ramos and Arnsten 2007),
sleep (Berridge et al. 2012), depression (Stone et al.
2003), and pain (Pertovaara 2006). Hence, further test for
M-current inhibition would seem worthwhile. From the
data of Legendre et al. (1988), a plausible start-point
might be the spinal cord.
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Fig. 2 Effects of a oxotremorine-M (oxo-M, 10 lM) and b phenyl-
ephrine (Phe, 10 lM) on action potential firing in two neurons
induced by 2 s depolarizing current injections (120 pA in a, 160 pA
in b). Neuron A: wild-type; neuron B: pre-injected with a1a cDNA.
c Plots of the number of action potentials (‘‘spikes’’) recorded in 2 s
(ordinates) against the amplitude of the depolarizing current injection
(abscissae) for the two cells illustrated in a and b. Discharges reverted
to control after drug washout
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